SC
ARVN icon

SummitTX Capital’s Arvinas ARVN Stock Holding History

SummitTX Capital’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,195
Closed -$99.6K – 738
2025
Q1 		$99.6K Buy
+14,195
New +$222K ﹤0.01% 758

Other funds holding ARVN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

SummitTX Capital's ARVN Position: Q2 2025 in Review

SummitTX Capital sold out of Arvinas (ARVN) in Q2 2025, closing a stake of 14,195 shares — an estimated $99.6K sold.

SummitTX Capital first reported a position in ARVN in Q1 2025 and held it in 1 quarter. The position peaked at $99.6K in Q1 2025. 215 funds tracked by Wall St. Rank hold ARVN as of Q2 2025.

  • SummitTX Capital reported no remaining Arvinas position as of Q2 2025 after selling out during the quarter.
  • SummitTX Capital sold 14,195 Arvinas shares in Q2 2025, an estimated $99.6K.
  • SummitTX Capital first reported a position in Arvinas in Q1 2025 and held it in 1 quarter.
  • SummitTX Capital's Arvinas position peaked at $99.6K in Q1 2025.
  • 215 funds tracked by Wall St. Rank held Arvinas as of Q2 2025.

Based on SummitTX Capital's 13F filing for Q2 2025, filed 14 Aug 2025.